We are live on ! Find out more
BC

Blackhill Capital Portfolio holdings

AUM $1.94B
1-Year Est. Return 18.09%
This Fund
S&P 500
This Quarter Est. Return
+12.13%
1 Year Est. Return
+18.09%
3 Year Est. Return
+164.47%
5 Year Est. Return
+136.25%
10 Year Est. Return
+688.12%
AUM
$829M
AUM Growth
+$89.4M
Cap. Flow
+$6.36M
Cap. Flow %
0.77%
Top 10 Hldgs %
82.19%
Holding
59
New
3
Increased
8
Reduced
8
Closed
1

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$3.59M
2
ELAN icon
Elanco Animal Health
ELAN
+$3.26M
3
WSM icon
Williams-Sonoma
WSM
+$894K
4
VTRS icon
Viatris
VTRS
+$800K
5
KRON
Kronos Bio
KRON
+$267K

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$981K
2
PFE icon
Pfizer
PFE
+$791K
3
PM icon
Philip Morris
PM
+$389K
4
ZBH icon
Zimmer Biomet
ZBH
+$196K
5
ZTS icon
Zoetis
ZTS
+$97.6K

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 49.99%
2 Healthcare 32.03%
3 Technology 6.33%
4 Communication Services 4.6%
5 Consumer Staples 2.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WSM icon
1
Williams-Sonoma
WSM
$29.5B
$409M 49.33%
8,030,260
+17,460
+0.2% +$894K
ZTS icon
2
Zoetis
ZTS
$31.1B
$40M 4.82%
241,566
-600
-0.2% -$97.6K
AAPL icon
3
Apple
AAPL
$4.45T
$36.4M 4.39%
274,500
-420
-0.2% -$50.5K
ABT icon
4
Abbott
ABT
$190B
$35.3M 4.26%
322,830
– –
DIS icon
5
Walt Disney
DIS
$179B
$34.3M 4.14%
189,300
– –
BMY icon
6
Bristol-Myers Squibb
BMY
$130B
$26.6M 3.21%
428,964
+800
+0.2% +$49.2K
ABBV icon
7
AbbVie
ABBV
$442B
$26.5M 3.2%
247,260
– –
LLY icon
8
Eli Lilly
LLY
$1.08T
$25M 3.01%
148,023
-6,571
-4% -$981K
JNJ icon
9
Johnson & Johnson
JNJ
$626B
$24.6M 2.97%
156,230
+150
+0.1% +$22.1K
MRK icon
10
Merck
MRK
$322B
$23.7M 2.86%
304,182
+46,950
+18% +$3.59M
MSFT icon
11
Microsoft
MSFT
$3.74T
$15.8M 1.9%
70,850
+150
+0.2% +$32.3K
ZBH icon
12
Zimmer Biomet
ZBH
$18.5B
$15M 1.81%
100,322
-1,391
-1% -$196K
PFE icon
13
Pfizer
PFE
$152B
$14.6M 1.76%
395,439
-21,565
-5% -$791K
ELAN icon
14
Elanco Animal Health
ELAN
$11.4B
$13.2M 1.6%
431,171
+106,700
+33% +$3.26M
KMB icon
15
Kimberly-Clark
KMB
$36.1B
$11.5M 1.38%
85,000
– –
CAT icon
16
Caterpillar
CAT
$388B
$10.9M 1.32%
60,000
– –
BAX icon
17
Baxter International
BAX
$14.3B
$9.8M 1.18%
122,200
– –
MA icon
18
Mastercard
MA
$492B
$7.14M 0.86%
20,000
– –
PG icon
19
Procter & Gamble
PG
$338B
$6.24M 0.75%
44,871
– –
CI icon
20
Cigna
CI
$72.4B
$5.12M 0.62%
24,587
– –
BRK.B icon
21
Berkshire Hathaway Class B
BRK.B
$1.11T
$4.2M 0.51%
18,110
– –
AMZN icon
22
Amazon
AMZN
$2.94T
$4.02M 0.48%
24,660
+460
+2% +$73.4K
EPD icon
23
Enterprise Products Partners
EPD
$81.8B
$2.93M 0.35%
149,570
– –
MDT icon
24
Medtronic
MDT
$116B
$2.83M 0.34%
24,177
– –
TCP
25
DELISTED
TC Pipelines LP
TCP
$2.81M 0.34%
95,400
– –
1
2 3

Similar funds

FFH
Fairfax Financial Holdings Toronto, Ontario, Canada $1.94B AUM 27.76% 1-Year Est. Return
OCM
Osterweis Capital Management San Francisco, California $1.94B AUM 20.77% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return
HC
Hamilton Capital Columbus, Ohio $1.93B AUM
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return

Blackhill Capital's Q4 2020 Portfolio in Review

As of Q4 2020, Blackhill Capital held 59 positions worth $829M, up 12% from $740M the previous quarter. Its ten largest holdings account for 82% of the portfolio.

Blackhill Capital's Q4 2020 filing shows 3 new, 8 increased, 8 reduced and 1 closed positions. Its largest new stake was Viatris: 49,052 shares worth $919K. The largest sale was Eli Lilly, an estimated $981K.

By sector, the portfolio is most concentrated in Consumer Discretionary at 50% of assets, up from 50% a quarter earlier, followed by Healthcare and Technology.

  • Blackhill Capital's largest Q4 2020 buy was Viatris: 49,052 shares worth $919K.
  • Blackhill Capital added most to Merck in Q4 2020, an estimated $3.59M increase.
  • Blackhill Capital's biggest Q4 2020 reduction was Eli Lilly, cutting an estimated $981K.
  • Blackhill Capital fully exited Bristol-Myers Squibb Company Contingent Value Rights in Q4 2020, selling an estimated $63K.
  • Blackhill Capital's ten largest holdings make up 82% of its $829M portfolio in Q4 2020.
  • Blackhill Capital opened 3 new positions and closed 1 in Q4 2020.
  • Blackhill Capital's portfolio value rose 12% quarter-over-quarter to $829M.

Based on Blackhill Capital's 13F filing for Q4 2020, filed 8 Feb 2021.